<div dir="ltr"><div class="gmail_default" style="font-size:large"><br></div><div class="gmail_quote"><br>From: <b class="gmail_sendername">South Centre</b> <span dir="ltr"><<a href="mailto:south@southcentre.int">south@southcentre.int</a>></span><br></div><div class="gmail_quote"><h2 class="gmail-m_-4124985769646530616null" style="text-align:center;margin:0px;padding:0px;display:block;font-family:"Times New Roman",Times,Baskerville,Georgia,serif;font-size:26px;font-weight:bold;line-height:125%;letter-spacing:-0.75px;color:rgb(0,0,0)"><b>The International Debate on Generic Medicines of Biological Origin</b></h2><div><br></div><div>The South Centre is pleased to announce the publication of Policy Brief No. 50 entitled <b>"The International Debate on Generic Medicines of Biological Origin",</b> authored<b> </b>by Germán Velásquez, Special Adviser on Policy and Health of the South Centre.
<div class="gmail-m_-4124985769646530616wrapper" id="gmail-m_-4124985769646530616content">
<div id="gmail-m_-4124985769646530616inside_content">
<article>
</article><p style="margin:1em 0px;padding:0px;color:rgb(0,0,0);font-family:"Times New Roman",Times,Baskerville,Georgia,serif;font-size:15px;line-height:150%;text-align:left">The
debate on generic medicines is not new. What makes it different today
is that attacks levelled against biological generic products are couched
in even more “technical” and abstruse language. The high price of
biological drugs stems mainly from the introduction of barriers to the
entry of generics into the market. In any debate on the feasibility of
producing biological generic products identical to the ‘original’ ones,
it should be made clear that what are at stake are not identical
products but therapeutic equivalents.</p>
<p style="margin:1em 0px;padding:0px;color:rgb(0,0,0);font-family:"Times New Roman",Times,Baskerville,Georgia,serif;font-size:15px;line-height:150%;text-align:left"><i>El
debate sobre los medicamentos genéricos no es nuevo. La diferencia es
que los ataques que se enfrentan hoy en el caso de los productos de
origen biológico, están revestidos de un lenguaje más “técnico” y
abstruso. Los altos costos de este tipo de medicamentos se deben
fundamentalmente a la introducción de barreras para la entrada de
productos genéricos. En el debate sobre la factibilidad de producir
productos biológicos genéricios idénticos a los ‘originales’, hay que
tener en claro que no se buscan productos idénticos sino equivalentes
terapéuticamente.</i></p>
<p style="margin:1em 0px;padding:0px;color:rgb(0,0,0);font-family:"Times New Roman",Times,Baskerville,Georgia,serif;font-size:15px;line-height:150%;text-align:left"><i>Le
débat sur les médicaments génériques n’est pas nouveau. Ce qui est
différent est que les attaques auxquelles les produits génériques
d’origine biologique sont confrontés aujourd’hui s’expriment dans un
langage semblant plus “technique” et abstrus. Les coûts élevés de ces
médicaments sont principalement dus à l’introduction d’obstacles à
l’entrée des produits génériques. Dans le débat sur la factibilité de
produire des génériques biologiques identiques aux produits ‘originaux’
il doit être clair que l’objectif n’est pas d’avoir des produits
identiques mais équivalents du point de vue thérapeutique.</i></p>
To access the policy brief directly, go to this webpage: <a href="https://southcentre.us5.list-manage.com/track/click?u=fa9cf38799136b5660f367ba6&id=39b9cbcd34&e=4fac633f11" style="color:rgb(109,198,221);font-weight:normal;text-decoration:underline" target="_blank">https://www.<wbr>southcentre.int/policy-brief-<wbr>50-august-2018/</a>
<p style="margin:1em 0px;padding:0px;color:rgb(0,0,0);font-family:"Times New Roman",Times,Baskerville,Georgia,serif;font-size:15px;line-height:150%;text-align:left">To access the South Centre website, where you can also find other policy briefs, publications and news items, go to: <a href="https://southcentre.us5.list-manage.com/track/click?u=fa9cf38799136b5660f367ba6&id=aaed4448a2&e=4fac633f11" style="color:rgb(109,198,221);font-weight:normal;text-decoration:underline" target="_blank">http://www.southcentre.int</a>.</p>
</div>
</div><br></div></div></div>